These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2273459)

  • 1. Effect of aspirin and sulindac on methotrexate clearance.
    Furst DE; Herman RA; Koehnke R; Ericksen N; Hash L; Riggs CE; Porras A; Veng-Pedersen P
    J Pharm Sci; 1990 Sep; 79(9):782-6. PubMed ID: 2273459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin alters methotrexate disposition in rheumatoid arthritis patients.
    Stewart CF; Fleming RA; Germain BF; Seleznick MJ; Evans WE
    Arthritis Rheum; 1991 Dec; 34(12):1514-20. PubMed ID: 1747136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Baluom M; Samara E; Grossbard EB; Lau DT
    J Clin Pharmacol; 2011 Sep; 51(9):1310-8. PubMed ID: 21209239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
    Fahrig L; Brasch H; Iven H
    Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate.
    Najjar TA; Abou-Auda HS; Ghilzai NM
    Cancer Chemother Pharmacol; 1998; 42(5):423-8. PubMed ID: 9771959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML; McGuire WP; Lad TE; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.
    Furst DE
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():20-5. PubMed ID: 8535644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells.
    Yan KH; Lee LM; Hsieh MC; Yan MD; Yao CJ; Chang PY; Chen TL; Chang HY; Cheng AL; Lai GM; Chuang SE
    Oncol Rep; 2013 Sep; 30(3):1497-505. PubMed ID: 23799623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
    Kremer JM; Hamilton RA
    J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.